Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3Phase 2/3 1Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 1Hypoxia 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Nitroglycerin × Clear all
NCT01171170 2020-09-28

NVALT12

Dutch Society of Physicians for Pulmonology and Tuberculosis

Phase 2 Completed
223 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01210378 2019-02-15

Nitroglycerin

Maastricht Radiation Oncology

Phase 2 Terminated
47 enrolled
Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung

NCT00616031 2013-08-12

Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
150 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡